[Asia Economy Reporter Lee Seon-ae]



▲Celltrion= CT-P16, developed as a biosimilar of Avastin, received a recommendation for marketing approval targeting 30 European countries from the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency.


▲Hyungji Elite= Sold subsidiary Hyungji Esquaia to Fashion Group Hyungji for 8.9 billion KRW.


▲Lotte Holdings= Decided to dispose of 3,700 preferred shares of treasury stock.


▲Hyundai Construction= Selected as the construction company for the Seogeumsa Redevelopment Zone 6 housing redevelopment project worth 839.8 billion KRW.


▲Hyundai Heavy Industries= Won a contract from the Philippine Department of National Defense for six surface ships worth 749.9 billion KRW.


▲Hyosung Heavy Industries= Construction of a residential-commercial complex in Oncheon-dong, Busan, worth 112.4 billion KRW.


▲GS Construction= Selected as the constructor for the Busan Bugok Zone 2 redevelopment project worth 643.8 billion KRW.


▲Meta Labs= Decided on a third-party allotment capital increase worth 15 billion KRW.



▲Visang Education= Absorbed subsidiary Visang e-Learning through merger; no change in Visang Education’s management rights or major shareholder.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing